Marker Therapeutics Inc (MRKR)

[Phantom Lord]

I 100% agree. I've been assuming we see an offering by the end of Q2 but hopefully by shutting down the TPIV 200 trial in ovarian cancer that might push it out to Q3. Either way I still expect to see a raise this year if they can't come up with some form of non-dilutive funding. I think there is a decent chance we see a partnership for pancreatic cancer this year but I don't no when or even if it would come with enough up front cash in time to avoid further dilution. Unfortunately we just have to wait and see what happens.

In my past communication with the company on this matter they are aware they need to be negotiating the next financing terms from a position of power but at this point something needs to happen between now and then or they will have their backs against the wall. I hate that we just have to sit here and wait but unfortunately that's what happens sometimes.